Compound name
cdk12-in-2
Protein family
Protein Kinase
Target name
CDK12
Affinity biochemical (nM)
52
CG-Set
Kinase set
Recommended Concentration
1 µM
Compound EUbOPEN ID
EUB0001624a
SMILES
Cn1cc(-c2ccc(N(C(=O)NCc3ccccc3)[C@H]3CC[C@H](Nc4ccc(C#N)cn4)CC3)cc2)ccc1=O
InChIKey
HDJBGURZVALLMD-KWQFAZJVSA-N
NCBI gene ID
51755
UniProt ID
Q9NYV4
Synonyms
CRK7, CRKR, KIAA0904
Mode of action
Inhibitor
Affinity biochemical definition
IC50
Affinity biochemical assay type
Enzyme inhibition assay (using the LANCE System)
Affinity Biochemical Source Knowledge
https://pubmed.ncbi.nlm.nih.gov/30067358/
Affinity biochemical relation
=
Selectivity platform
SelectScreen® Profiling (Z-lyte assay)
Selectivity platform number of targets
246
Selectivity remarks
Screened at 1 µM, closest targets as % of inhibition: CSNK1G1 (43%), MAPK10 (51%), TAOK3 (n.d.); Screened at 1 µM (Select Screen profiling, Lantha screen, 143 kinases), closest targets as % of displacement: DYRK2 (80%), STK39 (82%), TAOK3 (94%), https://pubmed.ncbi.nlm.nih.gov/30067358/; Screened at 1 µM (Select Screen profiling, Adapta assay, https://pubmed.ncbi.nlm.nih.gov/30067358/;
In-vitro potency : IC50(CDK2) >100 µM (CDK2/CCNA2 radiometric assay), IC50(CDK9) = 16 µM (Enzyme Inhibition Assay using the LANCE System), IC50(CDK8) >10 µM (TR-FRET assay), IC50(CDK7)>10 µM (TR-FRET assay), IC50(CDK13) = 10 nM (Enzyme Inhibition Assay using the LANCE System), https://pubmed.ncbi.nlm.nih.gov/30067358/;
In-vitro potency : IC50(CDK2) >100 µM (CDK2/CCNA2 radiometric assay), IC50(CDK9) = 16 µM (Enzyme Inhibition Assay using the LANCE System), IC50(CDK8) >10 µM (TR-FRET assay), IC50(CDK7)>10 µM (TR-FRET assay), IC50(CDK13) = 10 nM (Enzyme Inhibition Assay using the LANCE System), https://pubmed.ncbi.nlm.nih.gov/30067358/;
Selectivity Source Knowledge
https://pubmed.ncbi.nlm.nih.gov/30067358/
Selectivity Number of Off-targets
2